Back to top

VOTING AND EXCHANGE TRUST AGREEMENT

Voting Agreement

VOTING AND EXCHANGE TRUST AGREEMENT | Document Parties: NORTH AMERICAN NATURAL GAS, INC | PURERAY ACQUISITION INC | PURERAY HOLDINGS INC You are currently viewing:
This Voting Agreement involves

NORTH AMERICAN NATURAL GAS, INC | PURERAY ACQUISITION INC | PURERAY HOLDINGS INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: VOTING AND EXCHANGE TRUST AGREEMENT
Governing Law: Washington     Date: 7/31/2008

VOTING AND EXCHANGE TRUST AGREEMENT, Parties: north american natural gas  inc , pureray acquisition inc , pureray holdings inc
50 of the Top 250 law firms use our Products every day

EXHIBIT 10.2

VOTING AND EXCHANGE TRUST AGREEMENT

THIS AGREEMENT is made the 24th day of July, 2008,

B E T W E E N:

NORTH AMERICAN NATURAL GAS, INC., a corporation existing under the laws of the State of Washington,

(hereinafter referred to as “PureRay U.S.” ) ,

- and -

PURERAY HOLDINGS ULC, an unlimited liability corporation formed under the laws of the Province of Alberta,

(hereinafter referred to as “PureRay Holdings” ),

- and -

PURERAY ACQUISITION INC., a corporation formed under the laws of Canada,

(hereinafter referred to as the “Corporation” ),

- and -

DEREK BLACKBURN , an individual resident in the Village of Manotick, in the Province of Ontario,

(hereinafter referred to as “Trustee” )

WHEREAS:

A.

 

the Corporation is a wholly-owned subsidiary of PureRay Holdings and PureRay Holdings is a wholly-owned subsidiary of PureRay U.S.;

 

 

 

B.

 

pursuant to a share purchase agreement dated July 24, 2008 (the “ Purchase Agreement ”), between PureRay U.S., PureRay Holdings, the Corporation and all of the shareholders of PureRay Corporation (“ PureRay ”), the Corporation has agreed to acquire all of the outstanding shares in the capital of PureRay and, in satisfaction of payment of the purchase price therefor, to issue one Exchangeable Shares (as hereinafter defined) for each such share of PureRay acquired by the Corporation;

 

 

 

C.

 

PureRay Holdings is to grant to and in favour of each holder of Exchangeable Shares (as hereinafter defined) the right to require PureRay Holdings to purchase from such holder all or any


 

 

 

 - 2 -

 

 

part of the Exchangeable Shares (as hereinafter defined) held by such holder on the terms and conditions set forth in this Agreement; and

 

 

 

D.

 

the parties desire to make appropriate provisions and to establish a procedure whereby the rights to require PureRay to purchase Exchangeable Shares (as hereinafter defined) from the holders thereto shall be exercisable by such holders from time to time;

NOW THEREFORE, in consideration of the respective covenants provided in this Agreement and for other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the parties agree as follows:

ARTICLE 1
DEFINITIONS AND INTERPRETATION

1.1 Definitions

In this Agreement, the following terms shall have the following meanings:

 

 

“Affiliate” of any person means any other person directly or indirectly controlled by, or under control of, that person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlled by” and “under common control of” ), as applied to any person, means the possession by another person, directly or indirectly, of the power to direct or cause the direction of the management and policies of that first mentioned person, whether through the ownership of voting securities, by contract or otherwise.

 

 

 

 

 

“Automatic Exchange Rights” means the benefit of the obligation of PureRay Holdings to effect the automatic exchange of PureRay U.S. Common Shares for Exchangeable Shares pursuant to section 5.11.

 

 

 

 

 

“Beneficiaries” means the registered holders from time to time of Exchangeable Shares, other than PureRay U.S. and its Affiliates.

 

 

 

 

 

“Beneficiary Votes” has the meaning ascribed thereto in section 4.2.

 

 

 

 

 

“Board of Directors” means the board of directors of the Corporation.

 

 

 

 

 

“Business Day” means any day on which commercial banks are open for business in Toronto, Ontario, other than a Saturday, a Sunday or a day observed as a holiday in Toronto, Ontario under the laws of the province of Ontario or the federal laws of Canada.

 

 

 

 

 

“Canadian Dollar Equivalent” means, in respect of an amount expressed in a currency other than Canadian dollars (the “Foreign Currency Amount”) at any date, the product obtained by multiplying: (i) the Foreign Currency Amount by (ii) the noon spot exchange rate on such date for such foreign currency expressed in Canadian dollars as reported by the Bank of Canada or, in the event such spot exchange rate is not available, such exchange rate on such date for such foreign currency expressed in Canadian dollars as may be deemed by the Board of Directors to be appropriate for such purpose.

 

 

 

 

 

“Current Market Price” means, in respect of a PureRay U.S. Common Share on any date, the Canadian Dollar Equivalent of the average of the closing bid and asked prices of PureRay U.S. Common Shares during a period of 20 consecutive trading days ending not more than three


 

- 3 -

 

 

trading days before such date on such stock exchange or automated quotation system on which the PureRay U.S. Common Shares are listed or quoted, as the case may be, as may be selected by the Board of Directors for such purpose; provided however, that if the PureRay U.S. Common Shares are not then quoted on any stock exchange or automated quotation system or if, in the opinion of the Board of Directors, the public distribution or trading activity of PureRay U.S. Common Shares during such period does not create a market which reflects the fair market value of a PureRay U.S. Common Share, then the Current Market Price of a PureRay U.S. Common Share shall be determined by the Board of Directors, in good faith and in its sole discretion, and provided further that any such selection, opinion or determination by the Board of Directors shall be conclusive and binding.

 

 

 

 

 

“Exchange Right” has the meaning ascribed thereto in section 5.l.

 

 

 

 

 

“Exchangeable Shares” means the non-voting exchangeable shares in the capital of the Corporation.

 

 

 

 

 

“Insolvency Event” means the institution by the Corporation of any proceeding to be adjudicated a bankrupt or insolvent or to be wound up, or the consent of the Corporation to the institution of bankruptcy, insolvency or winding-up proceedings against it, or the filing of a petition, answer or consent seeking dissolution or winding-up under any bankruptcy, insolvency or analogous laws, including without limitation the Companies Creditors’ Arrangement Act (Canada) and the Bankruptcy and Insolvency Act (Canada), and the failure by the Corporation to contest in good faith any such proceedings commenced in respect of the Corporation within 30 days of becoming aware thereof, or the consent by the Corporation to the filing of any such petition or to the appointment of a receiver, or the making by the Corporation of a general assignment for the benefit of creditors, or the admission in writing by the Corporation of its inability to pay its debts generally as they become due, or the Corporation not being permitted, pursuant to solvency requirements of applicable law, to redeem any Retracted Shares pursuant to section 5.7 of the Share Provisions.

 

 

 

 

 

“ITA” means the Income Tax Act (Canada), as amended.

 

 

 

 

 

“Liquidation Call Right” has the meaning ascribed thereto in the Share Provisions.

 

 

 

 

 

“Liquidation Event” has the meaning ascribed thereto in section 5.11(b).

 

 

 

 

 

“Liquidation Event Effective Date” has the meaning ascribed thereto in section 5.11(c).

 

 

 

 

 

“List” has the meaning ascribed thereto in section 4.6.

 

 

 

 

 

“Officer’s Certificate” means, with respect to PureRay U.S. or the Corporation, as the case may be, a certificate signed by any one officer or director of PureRay U.S. or the Corporation, as the case may be.

 

 

 

 

 

“Person” includes an individual, partnership, corporation, company, unincorporated syndicate or organization, trust, trustee, executor, administrator and other legal representative.

 

 

 

 

 

“PureRay U.S. Affiliates” means Affiliates of PureRay U.S.

 

 

 

 

 

“PureRay U.S. Common Share” means an authorized share of common stock, par value U.S. $0.0001, in the capital of PureRay U.S.


 

- 4 -

 

 

“PureRay U.S. Consent” has the meaning ascribed thereto in section 4.2.

 

 

 

 

 

“PureRay U.S. Meeting” has the meaning ascribed thereto in section 4.2.

 

 

 

 

 

“PureRay U.S. Special Voting Share” means an authorized share of Special Voting Stock of PureRay U.S., par value U.S.$0.0001, which entitles the holder of record to four votes in respect of each such share and one vote in respect of each one-quarter of a share, all of which shares are to be issued to, deposited with, and voted by, the Trustee as described herein.

 

 

 

 

 

“PureRay U.S. Successor” has the meaning ascribed thereto in section 11.1 (a).

 

 

 

 

 

“Redemption Call Right” has the meaning ascribed thereto in the Share Provisions.

 

 

 

 

 

“Remittance Date” has the meaning ascribed thereto in the Share Provisions.

 

 

 

 

 

“Retracted Shares” has the meaning ascribed thereto in section 5.7.

 

 

 

 

 

“Retraction Call Right” has the meaning ascribed thereto in the Share Provisions.

 

 

 

 

 

“Share Provisions” means the rights, privileges, restrictions and conditions attaching to the Exchangeable Shares.

 

 

 

 

 

“Support Agreement” means the support agreement made as of even date herewith between PureRay U.S., PureRay Holdings and the Corporation.

 

 

 

 

 

“Trust” means the trust created by this Agreement.

 

 

 

 

 

“Trust Estate” means the PureRay U.S. Special Voting Shares, any other securities, the Exchange Right, the Automatic Exchange Rights and any money or other property which may be held by the Trustee from time to time pursuant to this trust agreement.

 

 

 

 

 

“Voting Rights” means the voting rights attached to the PureRay U.S. Special Voting Shares.

1.2 Interpretation Not Affected by Headings, etc.

The division of this Agreement into Articles, sections and other portions and the insertion of headings are for convenience of reference only and should not affect the construction or interpretation of this Agreement. Unless otherwise indicated, all references to an “Article” or “section” followed by a number and/or a letter refer to the specified Article or section of this Agreement. The terms “this Agreement”, “hereof”, “herein” and “hereunder” and similar expressions refer to this Agreement and not to any particular Article, section or other portion hereof and include any agreement or instrument supplementary or ancillary hereto.

1.3 Number, Gender, etc.

Words importing the singular number only shall include the plural and vice versa. Words importing any gender shall include the feminine and the masculine.

1.4 Date for any Action


 

- 5 -

If any date on which any action is required to be taken under this Agreement is not a Business Day, such action shall be required to be taken on the next succeeding Business Day.

ARTICLE 2
PURPOSE OF AGREEMENT

2.1 Establishment of Trust

The purpose of this Agreement is to create the Trust for the benefit of the Beneficiaries, as herein provided. The Trustee will hold the PureRay U.S. Special Voting Shares in order to enable the Trustee to exercise the Voting Rights and will hold the Exchange Rights and the Automatic Exchange Rights in order to enable the Trustee to exercise such rights, in each case as trustee for and on behalf of the Beneficiaries as provided in this Agreement.

ARTICLE 3
PURERAY U.S. SPECIAL VOTING SHARES

3.1 Issue and Ownership of the PureRay U.S. Special Voting Shares

PureRay U.S. hereby issues to and deposits with the Trustee, 8,963,750 PureRay U.S. Special Voting Shares to be hereafter held of record by the Trustee as trustee for and on behalf of, and for the use and benefit of, the Beneficiaries and in accordance with the provisions of this Agreement. PureRay U.S. hereby acknowledges receipt from the Trustee as trustee for and on behalf of the Beneficiaries of good and valuable consideration (and the adequacy thereof) for the issuance of the PureRay U.S. Special Voting Shares by PureRay U.S. to the Trustee. During the term of the Trust and subject to the terms and conditions of this Agreement, the Trustee shall possess and be vested with full legal ownership of the PureRay U.S. Special Voting Shares and shall be entitled to exercise all of the rights and powers of an owner with respect to the PureRay U.S. Special Voting Shares provided that the Trustee shall:

 

(a)

 

hold the PureRay U.S. Special Voting Shares and the legal title thereto as trustee solely for the use and benefit of the Beneficiaries in accordance with the provisions of this Agreement; and

 

 

 

 

 

(b)

 

except as specifically authorized by this Agreement, have no power or authority to sell, transfer, vote or otherwise deal in or with the PureRay U.S. Special Voting Shares and the PureRay U.S. Special Voting Shares shall not be used or disposed of by the Trustee for any purpose other than the purposes for which this Trust is created pursuant to this Agreement.

3.2 Legended Share Certificates

The Corporation will cause each certificate representing Exchangeable Shares to bear an appropriate legend notifying the Beneficiaries of their right to instruct the Trustee with respect to the exercise of the Voting Rights in respect of the Exchangeable Shares of the Beneficiaries.

3.3 Safe Keeping of Certificate

The certificate(s) representing the PureRay U.S. Special Voting Shares shall at all times be held in safe keeping by the Trustee.


 

- 6 -

ARTICLE 4
EXERCISE OF VOTING RIGHTS

4.1 Voting Rights

The Trustee, as the holder of record of the PureRay U.S. Special Voting Shares, shall be entitled to all of the Voting Rights, including the right to vote in person or by proxy the PureRay U.S. Special Voting Shares on any matters, questions, proposals or propositions whatsoever that may properly come before the shareholders of PureRay U.S. at a PureRay U.S. Meeting or in connection with a PureRay U.S. Consent. The Voting Rights shall be and remain vested in and exercised by the Trustee. Subject to section 7.14:

 

(a)

 

the Trustee shall exercise the Voting Rights only on the basis of instructions received pursuant to this Article 4 from Beneficiaries entitled to instruct the Trustee as to the voting thereof at the time at which the PureRay U.S. Meeting is held; and

 

 

 

 

 

(b)

 

to the extent that no instructions are received from a Beneficiary with respect to the Voting Rights to which such Beneficiary is entitled, the Trustee shall not exercise or permit the exercise of such Voting Rights.

4.2 Number of Votes

With respect to all meetings of shareholders of PureRay U.S. at which holders of PureRay U.S. Common Shares are entitled to vote (each, a “PureRay U.S. Meeting”) and with respect to all written consents sought by PureRay U.S. from its shareholders including the holders of PureRay U.S. Common Shares (each, a “PureRay U.S. Consent”) , each Beneficiary shall be entitled to instruct the Trustee to cast and exercise one of the votes comprised in the Voting Rights for each Exchangeable Share owned of record by such Beneficiary on the record date established by PureRay U.S. or by applicable law for such PureRay U.S. Meeting or PureRay U.S. Consent, as the case may be (the “Beneficiary Votes”) , in respect of each matter, question, proposal or proposition to be voted on at such PureRay U.S. Meeting or in connection with such PureRay U.S. Consent.

4.3 Mailings to Shareholders

With respect to each PureRay U.S. Meeting and PureRay U.S. Consent, PureRay U.S. will mail (or otherwise communicate in the same manner as PureRay U.S. utilizes in communications to holders of PureRay U.S. Common Shares) to the Trustee and each of the Beneficiaries named in the List referred to in section 4.6, such mailing or communication to commence on the same day as the mailing or notice (or other communication) with respect thereto is commenced by PureRay U.S. to its shareholders:

 

(a)

 

a copy of such notice, together with any related materials to be provided to shareholders of PureRay U.S.;

 

 

 

 

 

(b)

 

a statement that such Beneficiary is entitled to instruct the Trustee as to the exercise of the Beneficiary Votes with respect to such PureRay U.S. Meeting or PureRay U.S. Consent or, pursuant to section 4.7, to attend such PureRay U.S. Meeting and to exercise personally the Beneficiary Votes thereat;

 

 

 

 

 

(c)

 

a statement as to the manner in which such instructions may be given to the Trustee, including an express indication that instructions may be given to the Trustee to give:

 

(i)

 

a proxy to such Beneficiary or his designee to exercise personally the Beneficiary


 

- 7 -

 

 

 

Votes; or

 

 

 

 

 

(ii)

 

a proxy to a designated agent or other representative of the management of PureRay U.S. to exercise such Beneficiary Votes;

 

(d)

 

a statement that if no such instructions are received from the Beneficiary, the Beneficiary Votes to which such Beneficiary is entitled will not be exercised;

 

 

 

 

 

(e)

 

a form of direction whereby the Beneficiary may so direct and instruct the Trustee as contemplated herein; and

 

 

 

 

 

(f)

 

a statement of the time and date by which such instructions must be received by the Trustee in order to be binding upon it, which in the case of a PureRay U.S. Meeting shall not be earlier than the close of business on the second Business Day before such meeting, and of the method for revoking or amending such instructions. For the purpose of determining Beneficiary Votes to which a Beneficiary is entitled in respect of any PureRay U.S. Meeting or PureRay U.S. Consent, the number of Exchangeable Shares owned of record by the Beneficiary shall be determined at the close of business on the record date established by PureRay U.S. or by applicable law for purposes of determining shareholders entitled to vote at such PureRay U.S. Meeting.

PureRay U.S. will notify the Trustee of any decision of the board of directors of PureRay U.S. with respect to the calling of any PureRay U.S. Meeting and shall provide all necessary information and materials to the Trustee in each case promptly and in any event in sufficient time to enable the Trustee to perform its obligations contemplated by this section 4.3.

4.4 Copies of Shareholder Information

PureRay U.S. will deliver to the Trustee and each Beneficiary, at the same time as such materials are first sent to holders of PureRay U.S. Common Shares, all proxy materials (including notices of PureRay U.S. Meetings but excluding proxies to vote PureRay U.S. Common Shares), information statements, reports (including without limitation, all interim and annual financial statements) and other written communications that, in each case, are to be distributed from time to time to holders of PureRay U.S. Common Shares (and all materials specifically directed to the Beneficiaries or to the Trustee for the benefit of the Beneficiaries by PureRay U.S.).

4.5 Other Materials

As soon as reasonably practicable after receipt by PureRay U.S. or shareholders of PureRay U.S. (if such receipt is known by PureRay U.S.) of any material sent or given by or on behalf of a third party to holders of PureRay U.S. Common Shares generally, including without limitation, dissident proxy and information circulars (and related information and material) and tender and exchange offer circulars (and related information and material), PureRay U.S. shall use its reasonable efforts to obtain and deliver to the Trustee and each Beneficiary copies thereof (unless the same has been provided directly to the Trustee and Beneficiaries by such third party).


 

- 8 -

4.6 List of Persons Entitled to Vote

The Corporation shall:

 

(a)

 

before each annual, general and special PureRay U.S. Meeting or the seeking of any PureRay U.S. Consent; and

 

 

 

 

 

(b)

 

forthwith upon each request made at any time by the Trustee or PureRay U.S. in writing,

prepare or cause to be prepared a list (a “List” ) of the names and addresses of the Beneficiaries arranged in alphabetical order and showing the number of Exchangeable Shares held of record by each such Beneficiary, in each case at the close of business on the date specified by the Trustee or PureRay U.S., as applicable, in such request or, in the case of a List prepared in connection with a PureRay U.S. Meeting or a PureRay U.S. Consent, at the close of business on the record date established by PureRay U.S. or pursuant to applicable law for determining the holders of PureRay U.S. Common Shares entitled to receive notice of and/or to vote at such PureRay U.S. Meeting or to give consent in connection with such PureRay U.S. Consent. Each such List shall be delivered to the Trustee or PureRay U.S., as applicable, promptly after receipt by the Corporation of such request or the record date for such meeting or seeking of consent, as the case may be. PureRay U.S. agrees to give the Corporation notice (with a copy to the Trustee) of the calling of any PureRay U.S. Meeting or the seeking of any PureRay U.S. Consent, together with the record dates therefor, sufficiently before the date of the calling of such meeting or seeking of such consent so as to enable the Corporation to perform its obligations under this section 4.6.

4.7 Entitlement to Direct Votes

Any Beneficiary named in a List prepared in connection with any PureRay U.S. Meeting or PureRay U.S. Consent will be entitle: (i) to instruct the Trustee in the manner described in section 4.3 with respect to the exercise of the Beneficiary Votes to which such Beneficiary is entitled, or (ii) to attend such meeting and personally exercise thereat, as the proxy of the Trustee, the Beneficiary Votes to which such Beneficiary is entitled.

4.8 Voting by Trustee, and Attendance of Trustee Representative at Meeting

(a)

 

In connection with each PureRay U.S. Meeting and PureRay U.S. Consent, the Trustee shall exercise, either in person or by proxy, in accordance with the instructions received from a Beneficiary pursuant to section 4.3, the Beneficiary Votes as to which such Beneficiary is entitled to direct the vote (or any lesser number thereof as may be set forth in the instructions); provided, however, that such written instructions are received by the Trustee from the Beneficiary before the time and date fixed by PureRay U.S. for receipt of such instruction in the notice given by PureRay U.S. to the Beneficiary pursuant to section 4.3.

 

 

 

(b)

 

The Trustee shall, or shall cause a representative who is empowered to sign and deliver on behalf of the Trustee, proxies for Voting Rights to attend each PureRay U.S. Meeting. Upon submission by a Beneficiary (or its designee) of identification satisfactory to the Trustee or the Trustee’s representative, and at the Beneficiary’s request, the Trustee or such representative shall sign and deliver to such Beneficiary (or its designee) a proxy to exercise personally the Beneficiary Votes as to which such Beneficiary is otherwise entitled hereunder to direct the vote, if such Beneficiary either: (i) has not previously given the Trustee instructions pursuant to section 4.3 in respect of such meeting, or (ii) submits to such representative written revocation of any such previous instructions. At such meeting, the Beneficiary exercising such Beneficiary Votes shall have the same rights as the Trustee to speak at the meeting in favour of any matter, question, proposal or


 

- 9 -

 

 

proposition, to vote by way of ballot at the meeting in respect of any matter, question, proposal or proposition, and to vote at such meeting by way of a show of hands in respect of any matter, question or proposition.

4.9 Distribution of Written Materials

Any written materials distributed by PureRay U.S. pursuant to this Agreement shall be sent by mail (or otherwise communicated in the same manner as PureRay U.S. utilizes in communications to holders of PureRay U.S. Common Shares) to each Beneficiary at its address as shown on the books of the Corporation and to the Trustee at its address set out in section 14.3 hereof.

4.10 Termination of Voting Rights

All of the rights of a Beneficiary with respect to the Beneficiary Votes exercisable in respect of the Exchangeable Shares held by such Beneficiary, including the right to instruct the Trustee as to the voting of or to vote personally such Beneficiary Votes, shall be deemed to be surrendered by the Beneficiary to the Corporation or PureRay Holdings, as the case may be, and such Beneficiary Votes and the Voting Rights represented thereby shall cease immediately upon the delivery by such holder to the Trustee of the certificates representing such Exchangeable Shares in connection with the exercise by the Beneficiary of the Exchange Right or the occurrence of the automatic exchange of Exchangeable Shares for PureRay U.S. Common Shares, as specified in Article 5 (unless, in either case, PureRay U.S. shall not have delivered the requisite PureRay U.S. Common Shares issuable in exchange therefor to the Trustee for delivery to the Beneficiaries), or upon the redemption of Exchangeable Shares pursuant to section 5 or 6 of the Share Provisions, or upon the effective date of the liquidation, dissolution or winding-up of the Corporation pursuant to section 4 of the Share Provisions, or upon the purchase of Exchangeable Shares from the holder thereof by PureRay Holdings pursuant to the exercise by PureRay Holdings of the Retraction Call Right, the Redemption Call Right or the Liquidation Call Right.

ARTICLE 5
EXCHANGE RIGHT AND AUTOMATIC EXCHANGE

5.1 Grant and Ownership of the Exchange Right

PureRay Holdings hereby grants to the Trustee as trustee for and on behalf of, and for the use and benefit of, the Beneficiaries: (i) the right (the “Exchange Right” ), upon the occurrence and during the continuance of an Insolvency Event, to require PureRay Holdings to purchase from each or any Beneficiary all or any part of the Exchangeable Shares held by the Beneficiary; and (ii) the Automatic Exchange Rights, all in accordance with the provisions of this Agreement. PureRay Holdings hereby acknowledges receipt from the Trustee as trustee for and on behalf of the Beneficiaries of good and valuable consideration (and the adequacy thereof) for the grant of the Exchange Right and the Automatic Exchange Rights by PureRay Holdings to the Trustee. During the term of the Trust and subject to the terms and conditions of this Agreement, the Trustee shall possess and be vested with full legal ownership of the Exchange Right and the Automatic Exchange Rights and shall be entitled to exercise all of the rights and powers of an owner with respect to the Exchange Right and the Automatic Exchange Rights, provided that the Trustee shall:

 

(a)

 

hold the Exchange Right and the Automatic Exchange Rights and the legal title thereto as trustee solely for the use and benefit of the Beneficiaries in accordance with the provisions of this Agreement; and


 

- 10 -

 

(b)

 

except as specifically authorized by this Agreement, have no power or authority to exercise or otherwise deal in or with the Exchange Right or the Automatic Exchange Rights, and the Trustee shall not exercise any such rights for any purpose other than the purposes for which the Trust is created pursuant to this Agreement.

5.2 Legended Share Certificates

The Corporation will cause each certificate representing Exchangeable Shares to bear an appropriate legend notifying the Beneficiaries of:

 

(a)

 

their right to instruct the Trustee with respect to the exercise of the Exchange Right in respect of the Exchangeable Shares held by a Beneficiary; and

 

 

 

 

 

(b)

 

the Automatic Exchange Rights.

5.3 General Exercise of Exchange Right

The Exchange Right shall be and remain vested in and exercisable by the Trustee. Subject to section 7.14, the Trustee shall exercise the Exchange Right only on the basis of instructions received pursuant to this Article 5 from Beneficiaries entitled to instruct the Trustee as to the exercise thereof. To the extent that no instructions are received from a Beneficiary with respect to the Exchange Right, the Trustee shall not exercise or permit the exercise of the Exchange Right.

5.4 Purchase Price

The purchase price payable by PureRay Holdings for each Exchangeable Share to be purchased by PureRay Holdings under the Exchange Right shall be an amount per share equal to: (i) the Current Market Price of an PureRay U.S. Common Share on the last Business Day before the day of closing of the purchase and sale of such Exchangeable Share under the Exchange Right, which shall be satisfied in full by PureRay Holdings causing to be sent to such holder one PureRay U.S. Common Share, plus (ii) to the extent not paid by the Corporation, an additional amount equivalent to the full amount of all declared and unpaid dividends on each such Exchangeable Share held by such holder on any dividend record date which occurred before the closing of the purchase and sale. The purchase price for each such Exchangeable Share so purchased may be satisfied only by PureRay Holdings delivering or causing to be delivered to the relevant Beneficiary one PureRay U.S. Common Share and on the applicable payment date a cheque for the balance, if any, of the purchase price without interest (but less any amounts withheld pursuant to section 5.12).

5.5 Exercise Instructions

Subject to the terms and conditions herein set forth, a Beneficiary shall be entitled, upon the occurrence and during the continuance of an Insolvency Event, to instruct the Trustee to exercise the Exchange Right with respect to all or any part of the Exchangeable Shares registered in the name of such Beneficiary on the books of the Corporation. To cause the exercise of the Exchange Right by the Trustee, the Beneficiary shall deliver to the Trustee, in person or by certified or registered mail, at the Trustee’s office at Suite 600, 3625 Cumberland Blvd., Atlanta, Georgia, 30339 or at such other place as the Trustee may from time to time designate by written notice to the Beneficiaries, the certificates representing the Exchangeable Shares which such Beneficiary desires PureRay Holdings to purchase, duly endorsed in blank for transfer, and accompanied by such other documents and instruments as may be required to effect a transfer of Exchangeable Shares under the Canada Business Corporations Act and the by-laws of


 

- 11 -

the Corporation and such additional documents and instruments as the Trustee may reasonably require, together with:

 

(a)

 

a duly completed form of notice of exercise of the Exchange Right, contained on the reverse of or attached to the Exchangeable Share certificates, stating: (i) that the Beneficiary thereby instructs the Trustee to exercise the Exchange Right so as to require PureRay Holdings to purchase from the Beneficiary the number of Exchangeable Shares specified therein, (ii) that such Beneficiary has good title to and owns all such Exchangeable Shares to be acquired by PureRay Holdings free and clear of all liens, claims and encumbrances, (iii) the names in which the certificates representing PureRay U.S. Common Shares issuable in connection with the exercise of the Exchange Right are to be issued, and (iv) the names and addresses of the persons to whom such new certificates should be delivered; and

 

 

 

 

 

(b)

 

payment (or evidence of payment satisfactory to the Trustee, the Corporation, PureRay U.S. and PureRay Holdings) of the taxes (if any) payable as contemplated by section 5.8 of this Agreement.

If only a part of the Exchangeable Shares represented by any certificate or certificates delivered to the Trustee are to be purchased by PureRay Holdings under the Exchange Right, a new certificate for the balance of such Exchangeable Shares shall be issued to the holder at the expense of the Corporation.

5.6 Delivery of PureRay U.S. Common Shares; Effect of Exercise

Promptly after receipt of the certificates representing the Exchangeable Shares which the Beneficiary desires PureRay Holdings to purchase under the Exchange Right, together with such documents and instruments of transfer and a duly completed form of notice of exercise of the Exchange Right (and payment of taxes, if any, payable as contemplated by section 5.8 or evidence thereof), duly endorsed in blank, the Trustee shall notify PureRay U.S., PureRay Holdings and the Corporation of its receipt of the same, which notice to PureRay U.S., PureRay Holdings and the Corporation shall constitute exercise of the Exchange Right by the Trustee on behalf of the holder of such Exchangeable Shares, and PureRay Holdings shall promptly thereafter deliver or cause to be delivered to the Beneficiary of such Exchangeable Shares (or to such other persons, if any, properly designated by such Beneficiary) the number of PureRay U.S. Common Shares issuable in connection with the exercise of the Exchange Right, and on the applicable payment date cheques for the balance, if any, of the total purchase price therefor without interest (but less any amounts withheld pursuant to section 5.12); provided, however, that no such delivery shall be made unless and until the Beneficiary requesting the same shall have paid (or provided evidence of payment satisfactory to the Trustee, the Corporation, PureRay Holdings and PureRay U.S.) the taxes (if any) payable as contemplated by section 5.8 of this Agreement. Immediately upon the giving of noti


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more